Evidence for receptor bound endothelin in renal but not in cardiac tissues from normal rats

Cardiovascular Research

Volumn 38, Issue 1, 1998, Pages 140-148

  Ferrari, Emile ^a   Talbodec, Anne ^a   Vigne, Paul ^b   Frelin, Christian ^b  

^a PASTEUR HOSPITAL   (France)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

BQ 123; Endothelin; Stoichiometric binding

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; PHOSPHORAMIDON;

ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIUM; CELL INTERACTION; DISSOCIATION; DRUG EFFECT; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; HEART MUSCLE CELL; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; STOICHIOMETRY; TARGET CELL;

ANIMALS; ENDOTHELIN-1; FEMALE; GLYCOPEPTIDES; HEART; HYDROGEN-ION CONCENTRATION; IODINE RADIOISOTOPES; KIDNEY; MALE; MYOCARDIUM; PEPTIDES, CYCLIC; PROTEASE INHIBITORS; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN;

EID: 0032051661     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00320-9     Document Type: Article

References (37)

1. [1] Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-733.
2. [2] Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-735.
3. [3] Masaki T. Endothelins: Homeostatic and compensatory actions in the circulatory and endocrine systems. Endocrine Rev 1993;14:256-268.
4. [4] Marsden TA, Schramek H, Dunn MJ. Renal actions of endothelins: linking cellular signalling pathways to kidney disease. Kidney Int 1994;45:336-344.
5. [5] Levin ER. Endothelins. N Engl J Med 1995;333:356-363.
6. [6] Cohn JN. Is there a role for endothelin in the natural history of heart failure?. Circulation 1996;97:604-606.
7. [7] Shimoyama H, Sabbah HN, Borzak S, Tanimura M, Shevlyagin S, Scicli G, Goldstein S. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure. Circulation 1996;94:779-784.
8. [8] Battistini B, D'Orleans-Juste P, Sirois P. Endothelins: circulating plasma levels and presence in other biological fluids. Lab Invest 1993;68:600-628.
9. [9] Löffler BM, Breu V, Clozel M. Effect of different endothelin receptor antagonists and of the novel non peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett 1993;333:108-110.
10. [10] Fukuroda T, Kujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994;199:1461-1465.
11. [11] Haynes WG, Ferro CJ, O'Kane KPJ, Somerville D, Lomax CC, Webb DJ. Systemic endothelin blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 1996;93:1860-1870.
12. [12] Frelin C, Guedin D. Why are circulating levels of endothelin so low?. Cardiovasc Res 1994;28:1613-1622.
13. [13] Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N, Jishage K, Ouchi Y, Azuma S, Toyoda Y, Ishikawa T, Kumada M, Yazaki Y. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994;368:703-710.
14. [14] Clozel M, Löffler BM, Breu V, Hilfiger L, Maire JP, Butscha B. Downregulation of endothelin receptors by autocrine production of endothelin-1. Am J Physiol 1993;265:C188-C192.
15. [15] Desmarets J, Gresser O, Guédin D, Frelin C. Interaction of endothelin-1 with cloned bovine ETA receptors: biochemical parameters and functional consequences. Biochemistry 1996;35:14868-14875.
16. [16] Seuven K, Kahan C, Hartmann T, Pouyssegur J. Strong and persistent activation of inositol lipid breakdown induced early mitogenic events but not Go to S phase progression in hamster fibroblasts. Comparison of thrombin and carbachol actions in cells expressing M1 muscarinic acetylcholine receptors. J Biol Chem 1990;265:22292-22299.
17. [17] Vigne P, Marsault R, Breittmayer JP, Frelin C. Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells. Biochem J 1990;266:415-420.
18. [18] Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye coupling. Anal Biochem 1976;72:248-254.
19. [19] Marsault R, Feolde E, Frelin C. Receptor externalization determines sustained contractile responses to endothelin-1 in the rat aorta. Am J Physiol 1993;264:C687-C693.
20. [20] Resink TJ, Scott-Burden T, Boulanger C, Weber E, Bühler F. Internalization of endothelin by cultured human vascular smooth muscle cells: Characterization and physiological significance. Mol Pharmacol 1990;38:244-252.
21. [21] Vigne P, Breittmayer JP, Frelin C. Competitive and non competitive interactions of BQ-123 with endothelin ETA receptors. Eur J Pharmacol 1993;245:229-232.
22. [22] Frelin C, Vigne P. Brain microvascular vasoactive agents: receptors and mechanism of action. In: Pardridge WM, editor, The Blood Brain Barrier. Cellular and Molecular Biology. New York: Raven Press, 1993.
23. 3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype. Eur J Pharmacol 1995;274:1-6.
24. [24] McMahon EG, Palomo MA, Moore WM. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1991;17:S29-S33. Suppl. 7.
25. [25] Karet FE, Davenport AP. Human kidney: endothelin isoforms detected by HPLC with radioimmunoassay and receptor subtypes detected using ligands BQ123 and BQ3020. J Cardiovasc Pharmacol 1993;22:S29-S33. Suppl. 8.
26. [26] McClellan G, Weisberg A, Rose D, Winegrad S. Endothelial cell storage and release of endothelin as a cardioregulatory mechanism. Circ Res 1994;75:85-96.
27. [27] Macarthur H, Warner TD, Wood EG, Corder R, Vane JR. Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun 1994;200:395-400.
28. [28] Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin by the first orally active endothelin receptor antagonist. Nature 1993;365:759-761.
29. [29] Gellai M, DeWolf R, Pullen M, Nambi P. Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rats. Kidney Int 1994;46:1287-1294.
30. [30] Doucet J, Gonzalez W, Michel JB. Endothelin antagonists in salt dependent hypertension associated with renal insufficiency. J Cardiovasc Pharmacol 1996;27:643-651.
31. + channels by endothelin-1 in distal nephron cells. Am J Physiol 1996;271:F451-F460.
32. [32] Terada Y, Tomita K, Nonagushi H, Marumo F. Different localization of two types of endothelin receptors mRNA in micro-dissected rat nephron segments using reverse transcriptase and polymerase chain reaction assay. J Clin Invest 1992;90:107-112.
33. [33] Edwards RM, Pullen M, Nambi P. Activation of endothelin ETB receptors increases glomerular cGMP via an L-arginine dependent pathway. Am J Physiol 1992;263:F1020-F1025.
34. [34] Kivlighn SD, Gabel RA, Siegl PK. Effects of BQ-123 on renal function and acute cyclosporin induced renal dysfunction. Kidney Int 1994;45:131-136.
35. [35] Ujie K, Terada Y, Nonoguchi H, Shinohara M, Tomita K, Marumo F. Messenger RNA expression and synthesis of endothelin-1 along rat nephron segments. J Clin Invest 1992;90:1043-1048.
36. [36] Pernow J, Hemsen A, Lundberg JM. Tissue specific distribution, clearance and vascular effects of endothelin-1 in the pig. Biochem Biophys Res Commun 1989;161:647-652.
37. [37] Shiba R, Yanagisawa M, Miyauchi T, Ishii Y, Kimura S, Uchiyama Y, Masaki T, Goto K. Elimination of intravenously injected endothelin-1 from the circulation of the rat. J Cardiovasc Pharmacol 1989;13:S98-S101. suppl. 5.